Colonial River Investments’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Colonial River Investments's GILD Position: Q2 2026 in Review
Colonial River Investments increased its Gilead Sciences (GILD) stake by 16% in Q2 2026, buying an estimated $73.4K and bringing the position to 3,965 shares worth $501K. The position accounts for 0.14% of the portfolio, ranked #128.
Colonial River Investments first reported a position in GILD in Q4 2022 and has held it in 13 quarters since. The position peaked at $841K in Q2 2024. 1,323 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Colonial River Investments held 3,965 shares of Gilead Sciences worth $501K as of Q2 2026.
- Colonial River Investments bought 557 Gilead Sciences shares in Q2 2026, an estimated $73.4K.
- Gilead Sciences made up 0.14% of Colonial River Investments's portfolio in Q2 2026, its #128 holding.
- Colonial River Investments first reported a position in Gilead Sciences in Q4 2022 and has held it in 13 quarters since.
- Colonial River Investments's Gilead Sciences position peaked at $841K in Q2 2024.
- 1,323 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Colonial River Investments's 13F filing for Q2 2026, filed 24 Jul 2026.